碳离子放疗对局部晚期非小细胞肺癌肿瘤乏氧的影响:18F-FMISO PET/CT评估
碳离子放疗后18F-FMISO PET/CT测得的肿瘤乏氧参数显著降低;放疗前有无乏氧者局部控制率相似;18F-FDG摄取联合放疗后乏氧状态对局部控制有最强预测价值。
要点
- 碳离子放疗后18F-FMISO PET/CT显示的肿瘤乏氧显著减少。
- 放疗前有无乏氧者局部控制率相似(75.5% vs 85.5%,p=0.799)。
- 18F-FDG高摄取联合放疗后乏氧对局部控制预测价值最强(AUC 0.783)。
核心结论
- 碳离子放疗后局部晚期非小细胞肺癌的肿瘤乏氧显著降低。
- 放疗前有无乏氧者局部控制相似,放疗后乏氧清除呈局部控制改善的非显著趋势。
- 联合18F-FMISO与18F-FDG PET/CT可能提供更强的预后价值。
研究设计与样本
- 回顾性分析接受碳离子放疗的IIB-IIIC期非小细胞肺癌患者。
- 患者基线接受18F-FMISO和18F-FDG PET/CT,放疗后接受18F-FMISO PET/CT。
- 分析直径≥3 cm的感兴趣区(ROI),乏氧定义为肿瘤肌肉比(TMR)≥1.4。
- 生存分析采用Kaplan-Meier曲线,组间比较采用Log-rank检验。
主要发现
- 碳离子放疗后所有18F-FMISO参数显著降低。
- 放疗前有无乏氧的ROI局部控制率分别为75.5%和85.5%(p=0.799)。
- 放疗前后乏氧体积重叠比例为58.13%-81.34%。
- 18F-FDG高摄取与低摄取组局部控制率分别为46.8%和95.8%(p=0.0004),联合放疗后乏氧状态的AUC为0.783(p=0.01)。
关键数值与推荐
- 乏氧判定标准为18F-FMISO PET/CT的TMR≥1.4。
- ROI直径需≥3 cm。
- 联合18F-FDG摄取与放疗后乏氧状态预测局部控制的AUC为0.783(p=0.01)。
临床怎么用
- 碳离子放疗可显著降低肿瘤乏氧,支持其用于局部晚期非小细胞肺癌。
- 联合18F-FMISO与18F-FDG PET/CT可能有助于预后分层。
- 多示踪剂PET/CT引导的个体化碳离子剂量绘画策略值得进一步研究。
局限性
- 回顾性研究设计。
- 放疗后乏氧清除对局部控制的改善仅为非显著趋势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The study aimed to assess the impact of carbon-ion radiotherapy (CIRT) on intratumoral hypoxia in patients with locally advanced non-small cell lung cancer (LA-NSCLC) and the predictive value of 18F-fluoromisonidazole (FMISO) and 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT). METHODS: We retrospectively analyzed patients with stage IIB-IIIC NSCLC treated with CIRT who underwent baseline 18F-FMISO and 18F-FDG PET/CT and post-CIRT 18F-FMISO PET/CT. Regions of interest (ROIs) with a diameter ≥ 3 cm were analyzed. An ROI was defined as hypoxia with a tumor-to-muscle ratio (TMR) ≥ 1.4 on 18F-FMISO PET/CT. Survival outcomes were evaluated using Kaplan-Meier curves, and group comparisons were performed using Log-rank test. RESULTS: Thirty-seven eligible patients with 42 ROIs were included. Significant reductions in all 18F-FMISO parameters were observed after CIRT. ROIs with or without pre-CIRT hypoxia achieved similar local control (LC, with vs. without hypoxia: 75.5% vs. 85.5%, p = 0.799). The overlap ratios of hypoxic volumes between pre-/post-CIRT were 58.13%-81.34%. The combination of 18F-FDG uptake and post-CIRT hypoxia status demonstrated the strongest predictive value for LC (high vs. low uptake: 46.8% vs. 95.8%, p = 0.0004) with the highest area under the receiver operating characteristic curve (0.783, p = 0.01) among all evaluated combinations. CONCLUSION: Tumor hypoxia detected by 18F-FMISO PET/CT was significantly decreased after CIRT in patients with LA-NSCLC. Similar LC was achieved in patients with or without pre-CIRT hypoxia, while post-CIRT hypoxia clearance resulted in a non-significant trend toward improved LC. Combining 18F-FMISO and 18F-FDG PET/CT might provide enhanced prognostic value. Further investigation is warranted to explore individualized CIRT dose painting strategies guided by multi-tracer PET/CT imaging.
引用
- Chen J, Cheng J, Ma N, et al. Impact of carbon-ion radiotherapy on tumor hypoxia detected by 18F-FMISO PET/CT in locally advanced non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2026. PMID: 41555089. doi:10.1007/s00259-025-07702-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。